Litigation Department of the Year - Intellectual Property — Winner
Firm honored for securing high-profile and precedent-setting IP litigation wins across practices, industries, and jurisdictions.
David Frazier is a partner in the Washington, D.C. office and member of the Intellectual Property Litigation Practice. He devotes his practice to litigation and strategic counseling in the area of pharmaceuticals and biologics, particularly antibodies.
Dr. Frazier’s practice focuses primarily on patent litigation, strategic client counseling, due diligence analysis, and providing opinions in a variety of industries including:
Dr. Frazier has robust experience in pre-litigation, litigation, and trial, both for Hatch-Waxman and traditional biopharmaceutical patent litigation. Dr. Frazier also has experience in PTAB proceedings and strategy. He recently secured a significant victory at the PTAB when the Board denied institution of IPR's filed against formulation patent on a leading biological product with annual US sales in excess of US$8 billion per year.
Prior to joining Latham, Dr. Frazier was a partner in the patent litigation practice at a global intellectual property law firm.
In addition to his practice, Dr. Frazier serves as a member of the firm's Recruiting Committee. He is a member of the Federal Circuit Bar Association, the American Intellectual Property Association, and the American Association for the Advancement of Science.
Dr. Frazier’s representative experience includes:
*Matters handled prior to joining Latham
Firm honored for securing high-profile and precedent-setting IP litigation wins across practices, industries, and jurisdictions.
IP Litigation Practice recognized by Law360 for victories in several high-profile matters for LG Energy Solution, Peloton, and Astellas.
IP Litigation Practice recognized by Law360 for victories in several high-profile matters for LG Energy Solutions, Peloton, and Astellas.